1.华北理工大学研究生学院,唐山 063210
2.河北省人民医院内分泌科,石家庄 050051
3.河北省人民医院检验科, 石家庄 050051
4.河北北方学院研究生学院,张家口 075132
5.河北医科大学研究生学院,石家庄 050051
Received:11 February 2023,
Revised:2023-03-21,
Accepted:17 April 2023,
Published:28 June 2023
移动端阅览
孙文文,邢煜铃,霍丽静,等.TYG-BMI在维生素D和非酒精性脂肪肝中的中介作用[J].重庆医科大学学报,2023,48(6):647-655.
Sun Wenwen,Xing Yuling,Huo Lijing,et al.Mediating role of TYG-BMI in vitamin D and nonalcoholic fatty liver disease[J].Journal of Chongqing Medical University,2023,48(6):647-655.
孙文文,邢煜铃,霍丽静,等.TYG-BMI在维生素D和非酒精性脂肪肝中的中介作用[J].重庆医科大学学报,2023,48(6):647-655. DOI: 10.13406/j.cnki.cyxb.003250.
Sun Wenwen,Xing Yuling,Huo Lijing,et al.Mediating role of TYG-BMI in vitamin D and nonalcoholic fatty liver disease[J].Journal of Chongqing Medical University,2023,48(6):647-655. DOI: 10.13406/j.cnki.cyxb.003250.
目的
2
分析维生素D水平、甘油三酯葡萄糖-体质指数(triglyceride glucose-body mass index,TYG-BMI)与2型糖尿病(type 2 diabetes,T2DM)合并非酒精性脂肪肝(nonalcoholic fatty liver disease,NAFLD)患者的相关性,探讨TYG-BMI在维生素D缺乏对NAFLD影响中的作用。
方法
2
纳入河北省人民医院内分泌科住院的434例成年T2DM患者为研究对象。收集患者的人口学基本信息和血液指标,NAFLD通过超声诊断。维生素D缺乏定义为25-羟基维生素D[25-hydroxyvitamin D,25(OH)D]<20 ng/mL。采用Spearman相关分析方法,探讨25(OH)D、TYG-BMI和T2DM合并NAFLD危险因素之间的相关性。采用多元逻辑回归分析方法探讨25(OH)D、TYG-BMI与NAFLD之间的联系。采用中介分析方法探索TYG-BMI是否介导25(OH)D和NAFLD之间的联系。
结果
2
①在所有纳入的T2DM患者中,NAFLD组比无NAFLD组的25(OH)D水平更低[15.89(12.33,19.94) vs. 18.27(14.05,24.63),
P<
0.05],TYG-BMI水平更高[213.59(191.92,237.60) vs. 176.91(159.55,196.86),
P<
0.05],并且男性和女性均有同样的变化趋势(
P
<
0.05)。②按照25(OH)D水平不同分组发现,维生素D缺乏组的NAFLD患病率(60.1%)高于维生素D不足组(45.4%)及维生素D充足组(23.3%),差异存在统计学意义(
P
<
0.05)。③无论是男性患者还是女性患者,血清25(OH)D水平均与TYG-BMI呈负相关(男:
r
=-0.215,
P
<
0.001;女:
r
=-0.271,
P
<
0.001)。④采用logistic回归调整混杂因素后发现维生素D缺乏是T2DM患者发生NAFLD的危险因素(Model 1
OR
=2.347,95%CI=1.423~3.871,
P
=0.001;Model 2
OR
=2.478,95%CI=1.472~4.172,
P
=0.001;Model 3
OR
=2.057,95%CI=1.172~3.610,
P
=0.012)。进一步按性别分亚组进行logistic回归分析,仅在女性中发现维生素D缺乏是T2DM患者发生NAFLD的独立危险因素(Model 1
OR
=5.52,95%CI=2.008~15.177,
P
=0.001;Model 2
OR
=5.342,95%CI=1.776-16.061,
P
=0.003;Model 3
OR
=3.734,95%CI=1.108~12.578,
P
=0.034)。⑤在所有患者、男性患者和女性患者中TYG-BMI与NAFLD患病率均呈正相关(
P
<
0.05)。⑥中介分析发现在所有患者或女性患者中,TYG-BMI部分介导了25(OH)D对NAFLD患病率的间接影响(中介百分比:所有患者58.66%,女性患者38.07%),而男性没有。
结论
2
仅在女性T2DM患者中,维生素D缺乏与T2DM合并NAFLD发病率增加相关。其中维生素D缺乏导致T2DM合并NAFLD发生率增加的原因部分由TYG-BMI介导。
Objective
2
To analyze the correlation between the serum vitamin D and triglyceride glucose-body mass index(TYG-BMI) of type 2 diabetes mellitus(T2DM) patients complicated with nonalcoholic fatty liver disease(NAFLD),and to explore the roles played by TYG-BMI in the vitamin D deficiency of T2DM living with NAFLD.
Methods
2
A total of 434 patients with T2DM hospitalized at Department of Endocrinology,Hebei General Hospital were included in the study. These patients’ demographics and clinical data were collected. Abdominal ultrasonography was performed to diagnose NAFLD. Vitamin D deficiency was defined as that 25-hydroxyvitamin D[25(OH)D] vitamin levels were less than 20 ng/mL. Spearman correlation was used to test for an association among 25(OH)D,TYG-BMI and risk factors of NAFLD in T2DM. Multiple logistic regression was used to determine the association in 25(OH)D,TYG-BMI and NAFLD. Mediation analysis was used to explore whether TYG-BMI mediated the association between 25(OH)D and NAFLD.
Results
2
①In all included T2DM patients,the 25(OH)D level in patients with NAFLD was significantly lower[15.89(12.33,19.94) vs. 18.27(14.05,24.63),
P<
0.05] and TYG-BMI was significantly higher[213.59(191.92,237.60) vs. 176.91(159.55,196.86),
P<
0.05] compared with those without NAFLD. The data showed the same trends for males and females(
P
<
0.05). ②According to different 25(OH)D levels,the prevalence of NAFLD in the vitamin D deficiency group(60.1%) was higher than that in the vitamin D insufficiency group(45.4%) and the vitamin D sufficiency group(23.3%),and the difference was statistically significant(
P
<
0.05). ③Serum 25(OH)D level was negatively correlated with TYG-BMI, both in women and in men(men:
r
=-0.215,
P
<
0.001;women:
r
=-0.271,
P
<
0.001). ④After adjusting for confounding factors,multivariate logistic regression analysis revealed that Vitamin D deficiency was a risk factor for NAFLD in T2DM patients(Model 1
OR
=2.347,95%CI=1.423-3.871,
P
=0.001;Model 2
OR
=2.478,95%CI=1.472-4.172,
P
=0.001;Model 3
OR
=2.057,95%CI=1.172–3.610,
P
=0.012). Gender-specific subgroup logistic regression analyses showed vitamin D deficiency was an independent risk factor for NAFLD in T2DM for women(Model 1
OR
=5.52,95%CI=2.008-15.177,
P
=0.001;Model 2
OR
=5.342,95%CI=1.776-16.061,
P
=0.003;Model 3
OR
=3.734,95%CI=1.108-12.578,
P
=0.034). ⑤TYG-BMI was positively correlated with the prevalence of NAFLD in all T2DM patients,male patients and female patients(
P<
0.05). ⑥Mediation analysis indicated that TYG-BMI partly mediated the indirect effect of 25(OH)D on NAFLD incidence(percentage of mediation: 58.66% of all patients,and 38.07% of female patients).
Conclusion
2
Vitamin D deficiency is associated with an increased incidence of NAFLD only in female subjects with T2DM. The association between vitamin D deficiency and higher prevalence of NAFLD in T2DM may be at least partially mediated by TYG-BMI.
Xia C , Li R , Zhang S , et al . Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals [J ] . Eur J Clin Nutr , 2012 , 66 ( 9 ): 1035 - 1038 .
Stepanova M , Younossi ZM . Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population [J ] . Clin Gastroenterol Hepatol , 2012 , 10 ( 6 ): 646 - 650 .
Ekstedt M , Franzén LE , Mathiesen UL , et al . Long-term follow-up of patients with NAFLD and elevated liver enzymes [J ] . Hepatology , 2006 , 44 ( 4 ): 865 - 873 .
Mantovani A , Byrne CD , Bonora E , et al . Nonalcoholic fatty liver disease and risk of incident type 2 diabetes:a Meta-analysis [J ] . Diabetes Care , 2018 , 41 ( 2 ): 372 - 382 .
Ong MW , Tan CH , Cheng AKS . Prevalence and determinants of vitamin D deficiency among the overweight and obese singaporeans seeking weight management including bariatric surgery:a relationship with bone health [J ] . Obes Surg , 2018 , 28 ( 8 ): 2305 - 2312 .
Alagacone S , Verga E , Verdolini R , et al . The association between vitamin D deficiency and the risk of resistant hypertension [J ] . Clin Exp Hypertens , 2020 , 42 ( 2 ): 177 - 180 .
Hariri M , Zohdi S . Effect of vitamin D on non-alcoholic fatty liver disease:a systematic review of randomized controlled clinical trials [J ] . Int J Prev Med , 2019 , 10 : 14 .
Machado M , Cortez-Pinto H . Non-alcoholic fatty liver disease and insulin resistance [J ] . Eur J Gastroenterol Hepatol , 2005 , 17 ( 8 ): 823 - 826 .
Er LK , Wu S , Chou HH , et al . Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals [J ] . PLoS One , 2016 , 11 ( 3 ): e0149731 .
Raimi TH , Dele-Ojo BF , Dada SA , et al . Triglyceride-glucose index and related parameters predicted metabolic syndrome in nigerians [J ] . Metab Syndr Relat Disord , 2021 , 19 ( 2 ): 76 - 82 .
Li YX , You AJ , Tomlinson B , et al . Insulin resistance surrogates predict hypertension plus hyperuricemia [J ] . J Diabetes Investig , 2021 , 12 ( 11 ): 2046 - 2053 .
Wang RS , Dai LL , Zhong YJ , et al . Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease:insights from a general population [J ] . Lipids Health Dis , 2021 , 20 ( 1 ): 77 .
Wang XY , Liu JD , Cheng ZY , et al . Triglyceride glucose-body mass index and the risk of diabetes:a general population-based cohort study [J ] . Lipids Health Dis , 2021 , 20 ( 1 ): 99 .
Li N , Tan HW , Xie AX , et al . Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes [J ] . BMC Endocr Disord , 2022 , 22 ( 1 ): 101 .
Yuan Y , Sun W , Kong XQ . Comparison between distinct insulin resistance indices in measuring the development of hypertension:the China Health and Nutrition Survey [J ] . Front Cardiovasc Med , 2022 , 9 : 912197 .
Xue Y , Xu JH , Li M , et al . Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis:triglyceride glucose index-related parameters [J ] . Front Endocrinol , 2022 , 13 : 951689 .
Cho YK , Lee J , Kim HS , et al . Triglyceride glucose-waist circumference better predicts coronary calcium progression compared with other indices of insulin resistance:a longitudinal observational study [J ] . J Clin Med , 2020 , 10 ( 1 ): 92 .
赵长英 , 甘西伦 , 王明霜 , 等 . 维生素D缺乏与Graves病及其并发症关系的临床研究 [J ] . 重庆医科大学学报 , 2018 , 43 ( 6 ): 814 - 818 .
Zhao CY , Gan XL , Wang MS , et al . Clinical research on the deficiency of vitamin D with autoimmune thyroid disease [J ] . J Chongqing Med Univ , 2018 , 43 ( 6 ): 814 - 818 .
Holick MF . Vitamin D deficiency [J ] . N Engl J Med , 2007 , 357 ( 3 ): 266 - 281 .
Barchetta I , Angelico F , Del Ben M , et al . Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes [J ] . BMC Med , 2011 , 9 : 85 .
Chung GE , Kim D , Kwak MS , et al . The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease [J ] . Clin Mol Hepatol , 2016 , 22 ( 1 ): 146 - 151 .
Eliades M , Spyrou E , Agrawal N , et al . Meta-analysis:vitamin D and non-alcoholic fatty liver disease [J ] . Aliment Pharmacol Ther , 2013 , 38 ( 3 ): 246 - 254 .
Lonardo A , Suzuki A . Sexual dimorphism of NAFLD in adults. focus on clinical aspects and implications for practice and translational research [J ] . J Clin Med , 2020 , 9 ( 5 ): 1278 .
Sakurai M , Takamura T , Ota T , et al . Liver steatosis,but not fibrosis,is associated with insulin resistance in nonalcoholic fatty liver disease [J ] . J Gastroenterol , 2007 , 42 ( 4 ): 312 - 317 .
Zhang CH , Zhou BG , Sheng JQ , et al . Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies [J ] . Pharmacol Res , 2020 , 159 : 104984 .
Mota M , Banini BA , Cazanave SC , et al . Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease [J ] . Metabolism , 2016 , 65 ( 8 ): 1049 - 1061 .
Kitae A , Hashimoto Y , Hamaguchi M , et al . The triglyceride and glucose index is a predictor of incident nonalcoholic fatty liver disease:a population-based cohort study [J ] . Can J Gastroenterol Hepatol , 2019 , 2019 : 5121574 .
Lee SB , Kim MK , Kang S , et al . Triglyceride glucose index is superior to the homeostasis model assessment of insulin resistance for predicting nonalcoholic fatty liver disease in Korean adults [J ] . Endocrinol Metab , 2019 , 34 ( 2 ): 179 - 186 .
Loomba R , Friedman SL , Shulman GI . Mechanisms and disease consequences of nonalcoholic fatty liver disease [J ] . Cell , 2021 , 184 ( 10 ): 2537 - 2564 .
Takeuchi M , Takino JI , Sakasai-Sakai A , et al . Toxic AGE(TAGE)theory for the pathophysiology of the onset/progression of NAFLD and ALD [J ] . Nutrients , 2017 , 9 ( 6 ): 634 .
Morigny P , Houssier M , Mouisel E , et al . Adipocyte lipolysis and insulin resistance [J ] . Biochimie , 2016 , 125 : 259 - 266 .
Chacko SA , Song YQ , Manson JE , et al . Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women [J ] . Am J Clin Nutr , 2011 , 94 ( 1 ): 209 - 217 .
Kim MK , Kang MI , Oh KW , et al . The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects [J ] . Clin Endocrinol , 2010 , 73 ( 3 ): 330 - 338 .
Contreras-Bolívar V , García-Fontana B , García-Fontana C , et al . Mechanisms involved in the relationship between vitamin D and insulin resistance:impact on clinical practice [J ] . Nutrients , 2021 , 13 ( 10 ): 3491 .
Zhou QG , Hou FF , Guo ZJ , et al . 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells [J ] . Diabetes Metab Res Rev , 2008 , 24 ( 6 ): 459 - 464 .
Tamadon MR , Soleimani A , Keneshlou F , et al . Clinical trial on the effects of vitamin D supplementation on metabolic profiles in diabetic hemodialysis [J ] . Horm Metab , 2018 , 50 ( 1 ): 50 - 55 .
Haussler MR , Haussler CA , Bartik L , et al . Vitamin D receptor:molecular signaling and actions of nutritional ligands in disease prevention [J ] . Nutr Rev , 2008 , 66 (10 Suppl 2 ): S98 - S112 .
Ford ES , Ajani UA , McGuire LC , et al . Concentrations of serum vitamin D and the metabolic syndrome among U. S. adults [J ] . Diabetes Care , 2005 , 28 ( 5 ): 1228 - 1230 .
Abenavoli L , Milic N , Di Renzo L , et al . Metabolic aspects of adult patients with nonalcoholic fatty liver disease [J ] . World J Gastroenterol , 2016 , 22 ( 31 ): 7006 - 7016 .
Grammatiki M , Rapti E , Karras S , et al . Vitamin D and diabetes mellitus:causal or casual association? [J ] . Rev Endocr Metab Disord , 2017 , 18 ( 2 ): 227 - 241 .
0
Views
6
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
